ArticleThe Indian journal of medical research2025
Immunological memory in infected & exposure näive individuals one year post SARS-CoV-2 vaccination.
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Immunological memory in post SARS-CoV-2 vaccination.The Indian journal of medical research · 2025Article
- Authors' response.The Indian journal of medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives COVID-19 has affected millions and wreaked havoc on global healthcare systems as well as a devastating impact on the economies of various nations. Vaccines are highly pivotal in promoting an appropriate immune response. Understanding the effectiveness and stability of the vaccines is essential as these may differ across populations. Hence, this study explored the durability and efficacy of the COVISHIELD (ChAdOx1 nCoV-A) vaccine among healthcare workers (HCWs). Methods In this study, 84 HCWs who received two doses of COVISHIELD and had no breakthrough infections or precautionary doses were assessed. Participants were categorised into four groups (A, B, C, and D) based on pre-immunisation antibody status and SARS-CoV-2 RT-PCR results. Group A had prior infection and IgG antibodies, group B had RT-PCR positivity without detectable antibodies, group C had IgG antibodies without RT-PCR testing, and group D was exposure-näive. Humoral immunity was assessed by measuring IgG antibodies to the spike protein, while cell-mediated immunity was evaluated through SARS-CoV-2-specific T-cell markers and immunophenotyping. Results Over one year, a significant decrease in anti-spike IgG levels was observed in all groups (P<0.0001). It was observed that memory B cells declined significantly among all the groups over a period of one year [group A (P<0.0001), group B (P=0.0080), group C (P=0.0158), and group D (P=0.0004)]; no significant decrease inactivated T-cells was observed over a year. The mean of anti-spike IgG levels in samples from exposed participants (group A, B, C) versus non-exposed (group D) was significantly higher (P<0.0001). Interpretation & conclusions These findings indicate the need for regular booster doses of vaccination due to the waning of immunity by the vaccine. We also demonstrate that hybrid immunity (a combination of immune response post-natural infection and vaccination) provides better protection than vaccination alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.